Salvage Therapies for Metastatic Renal Cell Carcinoma
This lecture explores options for patients with metastatic renal cell carcinoma (RCC) following treatment with VEGF-TKI-targeted agents and ex options for patients with metastatic RCC following treatment with immune checkpoint inhibitors (ICIs), including other ICIs and agents with novel targets.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.